Vivelle News

Noven Announces 2007 Earnings Release Date - Business Wire (press release)

all 3 news articles

Posted: Thu Mar 06 17:01:38 -0500 2008

Noven to Present at Raymond James Institutional Investors Conference - PR-Inside.com (Pressemitteilung)

Noven's leading transdermal products utilize its proprietary DOT Matrix(R) drug delivery technology and include Vivelle-Dot(R) (estradiol transdermal ...

http://www.pr-inside.com/noven-to... | Posted: Fri Feb 29 11:16:18 -0500 2008

BioSante's Gamble Against Generics - Motley Fool

The drug could become a low-margin sub-$100 million treatment, like Novartis' (NYSE: NVS) and Noven Pharmaceuticals' (Nasdaq: NOVN) Vivelle-dot, ...

http://www.fool.com/investing/hig... | Posted: Tue Jan 29 13:49:38 -0500 2008

Instant Overview of the French Hair Styling Market for 2007 - Reuters

... Page 10 - Socio-Economic Data for France Page 11 - Snapshots Sources for Further Research Companies mentioned: - Vivelle Dop - LaScad/ LOreal - Ellnet ...

http://www.reuters.com/article/pr... | Posted: Tue Jan 08 04:01:26 -0500 2008

Instant Overview of the French Hair Styling Market for 2007 - Reuters

... Page 10 - Socio-Economic Data for France Page 11 - Snapshots Sources for Further Research Companies mentioned: - Vivelle Dop - LaScad/ LOreal - Ellnet ...

Posted: Tue Jan 08 04:01:26 -0500 2008

Noven's chief executive retires - Trading Markets (press release)

... Novogyne Pharmaceuticals, which has become a market leader in patches for post-menopausal female hormone treatments, such as the Vivelle-Dot patch. ...

Posted: Fri Jan 04 05:14:34 -0500 2008

Noven Announces Changes to Board of Directors and Senior Management - WELT ONLINE

Its commercialized transdermal products include Vivelle-Dot® (estradiol transdermal system), the most prescribed estrogen patch in the US, and Daytrana™ ...

http://newsticker.welt.de/index.p... | Posted: Thu Jan 03 08:25:44 -0500 2008